Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dewpoint Therapeutics
Biotech
Dewpoint collects new pharma partner for preclinical ALS program
Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering around an ALS program.
Gabrielle Masson
Dec 4, 2024 11:47am
Eikon, Dewpoint investors raise new $630 million fund
Jan 29, 2024 9:39am
Dewpoint trims headcount, pipeline to take condensates to clinic
Jan 17, 2024 11:10am
Novo Nordisk inks $745M biobucks pact with Dewpoint
Mar 22, 2023 11:15am
Leaping forward: Bayer VC arm doubles investment pace with $1.4B
Apr 1, 2022 9:59am
Dewpoint snags $150M for programs with Pfizer, Merck and Bayer
Feb 3, 2022 6:00am
